calcium chloride injection, USP - ANYSYR Adverse Reactions

()

6 ADVERSE REACTIONS

The following serious adverse reactions are also described elsewhere in the labeling:

•
End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates [see Warnings and Precautions (5.1)]
•
Hypotension, Bradycardia, Arrhythmias, and Syncope with Rapid Administration [see Warnings and Precautions (5.2)]
•
Arrhythmias with Concomitant Digoxin Use [see Warnings and Precautions (5.3)]
•
Tissue Necrosis and Calcinosis [see Warnings and Precautions (5.4)]
•
Aluminum toxicity [see Warnings and Precautions (5.5)]

The following adverse reactions have been identified in literature and postmarketing reports of calcium chloride. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure:

•
Nervous system disorders: Paraesthesia (upon rapid injection), calcium taste
•
General disorders and administration site conditions: Sense of oppression, sense of “heat wave”, local burning sensation, injection site extravasation, injection site reactions
•
Cardiovascular disorders: Peripheral vasodilatation, decreased blood pressure

Find calcium chloride injection, USP - ANYSYR medical information:

Find calcium chloride injection, USP - ANYSYR medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

calcium chloride injection, USP - ANYSYR Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

Adverse Reactions

6 ADVERSE REACTIONS

The following serious adverse reactions are also described elsewhere in the labeling:

•
End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates [see Warnings and Precautions (5.1)]
•
Hypotension, Bradycardia, Arrhythmias, and Syncope with Rapid Administration [see Warnings and Precautions (5.2)]
•
Arrhythmias with Concomitant Digoxin Use [see Warnings and Precautions (5.3)]
•
Tissue Necrosis and Calcinosis [see Warnings and Precautions (5.4)]
•
Aluminum toxicity [see Warnings and Precautions (5.5)]

The following adverse reactions have been identified in literature and postmarketing reports of calcium chloride. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure:

•
Nervous system disorders: Paraesthesia (upon rapid injection), calcium taste
•
General disorders and administration site conditions: Sense of oppression, sense of “heat wave”, local burning sensation, injection site extravasation, injection site reactions
•
Cardiovascular disorders: Peripheral vasodilatation, decreased blood pressure
Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5Pm ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.